Skip to main content

Peer Review reports

From: Efficacy and tolerability of sofosbuvir and daclatasvir for treatment of hepatitis C genotype 1 & 3 in patients undergoing hemodialysis- a prospective interventional clinical trial

Original Submission
9 May 2019 Submitted Original manuscript
9 Jun 2019 Author responded Author comments - Shafiq Ur Rehman Cheema
Resubmission - Version 2
9 Jun 2019 Submitted Manuscript version 2
13 Jun 2019 Author responded Author comments - Shafiq Ur Rehman Cheema
Resubmission - Version 3
13 Jun 2019 Submitted Manuscript version 3
10 Sep 2019 Author responded Author comments - Shafiq Ur Rehman Cheema
22 Jul 2019 Reviewed Reviewer Report - Masanori Atsukawa
2 Aug 2019 Reviewed Reviewer Report - Meghan E. Sise
Resubmission - Version 4
10 Sep 2019 Submitted Manuscript version 4
11 Oct 2019 Author responded Author comments - Shafiq Ur Rehman Cheema
10 Sep 2019 Reviewed Reviewer Report - Masanori Atsukawa
30 Sep 2019 Reviewed Reviewer Report - Meghan E. Sise
Resubmission - Version 5
11 Oct 2019 Submitted Manuscript version 5
16 Nov 2019 Author responded Author comments - Shafiq Ur Rehman Cheema
2 Nov 2019 Reviewed Reviewer Report - Masanori Atsukawa
3 Nov 2019 Reviewed Reviewer Report - Meghan E. Sise
Resubmission - Version 6
16 Nov 2019 Submitted Manuscript version 6
Publishing
20 Nov 2019 Editorially accepted
28 Nov 2019 Article published 10.1186/s12882-019-1631-4

You can find further information about peer review here.

Back to article page